These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A population-based study of metastatic colorectal cancer in individuals aged ≥ 80 years: findings from the South Australian Clinical Registry for Metastatic Colorectal Cancer. Kumar R; Jain K; Beeke C; Price TJ; Townsend AR; Padbury R; Roder D; Young GP; Richards A; Karapetis CS Cancer; 2013 Feb; 119(4):722-8. PubMed ID: 22990939 [TBL] [Abstract][Full Text] [Related]
23. Outcomes of irinotecan-based chemotherapy regimens in elderly Medicare patients with metastatic colorectal cancer. Obeidat NA; Pradel FG; Zuckerman IH; DeLisle S; Mullins CD Am J Geriatr Pharmacother; 2009 Dec; 7(6):343-54. PubMed ID: 20129255 [TBL] [Abstract][Full Text] [Related]
24. Multiagent regimens for metastatic colorectal cancer: if some is good, more must be better. Allegra C; George T; Yothers G J Natl Cancer Inst; 2011 Jan; 103(1):4-5. PubMed ID: 21123834 [No Abstract] [Full Text] [Related]
25. Advances in the treatment of metastatic colorectal cancer. Goldberg RM Oncologist; 2005; 10 Suppl 3():40-8. PubMed ID: 16368870 [TBL] [Abstract][Full Text] [Related]
26. 'Deepness of Response' Is Associated with Overall Survival in Standard Systemic Chemotherapy for Metastatic Colorectal Cancer. Nozawa H; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Hata K; Kazama S; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Watanabe T Chemotherapy; 2014; 60(5-6):360-7. PubMed ID: 26389969 [TBL] [Abstract][Full Text] [Related]
27. Combining curcumin (C3-complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancer (CUFOX): study protocol for a randomised control trial. Irving GR; Iwuji CO; Morgan B; Berry DP; Steward WP; Thomas A; Brown K; Howells LM Trials; 2015 Mar; 16():110. PubMed ID: 25872567 [TBL] [Abstract][Full Text] [Related]
28. Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy. Klaver YL; Simkens LH; Lemmens VE; Koopman M; Teerenstra S; Bleichrodt RP; de Hingh IH; Punt CJ Eur J Surg Oncol; 2012 Jul; 38(7):617-23. PubMed ID: 22572106 [TBL] [Abstract][Full Text] [Related]
29. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer. Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328 [TBL] [Abstract][Full Text] [Related]
30. [Adjuvant and palliative anticancer treatment of colon carcinoma in 2004]. Medinger M; Steinbild S; Mross K Praxis (Bern 1994); 2004 Sep; 93(40):1633-44. PubMed ID: 15495753 [TBL] [Abstract][Full Text] [Related]
31. The role of targeted therapy in the treatment of colorectal cancer. Goldberg RM; Hurwitz HI; Fuchs CS Clin Adv Hematol Oncol; 2006 Aug; 4(8 Suppl 17):1-10; quiz 11-2. PubMed ID: 17139241 [TBL] [Abstract][Full Text] [Related]
35. Can chemotherapy be discontinued in unresectable metastatic colorectal cancer? The GERCOR OPTIMOX2 Study. Chibaudel B; Maindrault-Goebel F; Lledo G; Mineur L; André T; Bennamoun M; Mabro M; Artru P; Carola E; Flesch M; Dupuis O; Colin P; Larsen AK; Afchain P; Tournigand C; Louvet C; de Gramont A J Clin Oncol; 2009 Dec; 27(34):5727-33. PubMed ID: 19786657 [TBL] [Abstract][Full Text] [Related]
36. A phase II study of bevacizumab, oxaliplatin, and capecitabine in patients with previously untreated metastatic colorectal cancer: a prospective, multicenter trial of the Korean Cancer Study Group. Hong YS; Lee SS; Kim KP; Lee JL; Kang YK; Shin SJ; Ahn JB; Jung KH; Im SA; Kim TY; Kim JH; Park YS; Kim TW Am J Clin Oncol; 2014 Feb; 37(1):19-23. PubMed ID: 23111359 [TBL] [Abstract][Full Text] [Related]
37. [Therapy of colorectal carcinoma in internal medicine]. Graeven U; Schmiegel W Praxis (Bern 1994); 2002 Oct; 91(43):1797-805. PubMed ID: 12432692 [TBL] [Abstract][Full Text] [Related]
38. Comparison of treatment outcome in metastatic colorectal cancer patients included in a clinical trial versus daily practice in The Netherlands. Mol L; Koopman M; van Gils CW; Ottevanger PB; Punt CJ Acta Oncol; 2013 Jun; 52(5):950-5. PubMed ID: 23517248 [TBL] [Abstract][Full Text] [Related]